Stock Events

Stock Events

IRIDEX 

$0.7000
10
-$0.00-0.1% 14:08 Today

Statistics

Day High
0.7056
Day Low
0.6998
52W High
1.65
52W Low
0.6998
Volume
37,059
Avg. Volume
67,298
Mkt Cap
12.18M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.1
-0.07
-0.04
-0.01
Expected EPS
-0.04
Actual EPS
N/A

Financials

-8.42%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
52.68MRevenue
-4.44MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Lumentum
LITE
Mkt Cap80.28B
Lumentum Holdings Inc. competes in the optical and laser technologies sector, similar to IRIDEX's focus on ophthalmic laser-based treatments.
Cooper Companies
COO
Mkt Cap13.88B
The Cooper Companies, Inc. offers medical devices for eye care, competing in the broader ophthalmology and optometry sectors alongside IRIDEX.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, offers products that compete in the eye health market, overlapping with IRIDEX's laser systems.
nVent Electric
NVT
Mkt Cap24.03B
nVent Electric Plc, while focused on electrical connection and protection, competes through its medical solutions, including technologies that can be applied in ophthalmology.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc., through its acquisition of Allergan, competes in the eye care market, particularly in treatments that could be alternatives to IRIDEX's solutions.
Align Technology
ALGN
Mkt Cap11.19B
Align Technology, Inc. competes indirectly by offering medical devices in the broader healthcare sector, including technologies that can impact eye care.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. competes by offering robotic-assisted surgical systems, some of which can be applied in surgeries that overlap with treatments offered by IRIDEX.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. competes in the healthcare and medical devices sector, offering products that can be used in a wide range of treatments, including those related to eye health.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation competes in the medical devices market, offering products that, while not directly competing in ophthalmology, are part of the broader healthcare and medical equipment industry.

About

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Show more...
CEO
Patrick Mercer
Employees
108
Country
United States
ISIN
US4626841013

Listings

XNAS
US
IRIX
BOATS
BOATS
IRIX.BOATS

0 Comments

Share your thoughts

FAQ

What is IRIDEX stock price today?▼
The current price of IRIX is $0.70 USD — it has decreased by -0.1% in the past 24 hours. Watch IRIDEX stock price performance more closely on the chart.
What is IRIDEX stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange IRIDEX stocks are traded under the ticker IRIX.
Is IRIDEX stock price growing?▼
IRIX stock has fallen by -0.92% compared to the previous week, the month change is a -14.65% fall, over the last year IRIDEX has showed a -46.97% decrease.
What is IRIDEX market cap?▼
Today IRIDEX has the market capitalization of 12.18M
When is the next IRIDEX earnings date?▼
IRIDEX is going to release the next earnings report on November 17, 2026.
What were IRIDEX earnings last quarter?▼
IRIX earnings for the last quarter are -0.07 USD per share, whereas the estimation was -0.01 USD resulting in a -600% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IRIDEX revenue for the last year?▼
IRIDEX revenue for the last year amounts to 52.68M USD.
What is IRIDEX net income for the last year?▼
IRIX net income for the last year is -4.44M USD.
How many employees does IRIDEX have?▼
As of September 04, 2026, the company has 108 employees.
In which sector is IRIDEX located?▼
IRIDEX operates in the Health & Wellness sector.
When did IRIDEX complete a stock split?▼
IRIDEX has not had any recent stock splits.
Where is IRIDEX headquartered?▼
IRIDEX is headquartered in MOUNTAIN VIEW, United States.